Help:WikiPathways Portals
From WikiPathways
(Difference between revisions)
(removed the word portal) |
|||
| Line 10: | Line 10: | ||
<br>WikiPathways has a growing list of portals: | <br>WikiPathways has a growing list of portals: | ||
| - | * [[Portal:Disease/COVIDPathways|COVID-19 | + | * [[Portal:Disease/COVIDPathways|COVID-19]] |
| - | * [[Portal:AOP|Adverse Outcome Pathway | + | * [[Portal:AOP|Adverse Outcome Pathway]] |
| - | * [[Portal:Lipids|Lipids Pathways | + | * [[Portal:Lipids|Lipids Pathways]] |
| - | * [[Portal:Blau|Blau Pathways | + | * [[Portal:Blau|Blau Pathways]] |
| - | * [[Portal:SkeletalDysplasia|Skeletal Dysplasia | + | * [[Portal:SkeletalDysplasia|Skeletal Dysplasia]] |
| - | * [[Portal:CPTAC|Clinical Proteomic Tumor Analysis Consortium Pathway | + | * [[Portal:CPTAC|Clinical Proteomic Tumor Analysis Consortium Pathway]] |
| - | * [[Portal:RenalGenomics|Renal Genomics | + | * [[Portal:RenalGenomics|Renal Genomics]] |
| - | * [[Portal:Disease|Disease | + | * [[Portal:Disease|Disease]] and [[Portal:RareDisease|Rare Disease]] |
| - | * [[Portal:ExRNA|ExRNA Pathway | + | * [[Portal:ExRNA|ExRNA Pathway]] |
| - | * [[Portal:Micronutrient|Micronutrients | + | * [[Portal:Micronutrient|Micronutrients]] |
| - | * [[Portal:Nanomaterials|Nanomaterials Pathways | + | * [[Portal:Nanomaterials|Nanomaterials Pathways]] |
| - | * [[Portal:NetPath|NetPath | + | * [[Portal:NetPath|NetPath]] |
* [[Portal:Plants|Plant Pathways]] | * [[Portal:Plants|Plant Pathways]] | ||
| - | * [[Portal:Reactome|Reactome | + | * [[Portal:Reactome|Reactome]] |
| - | * [[Portal:WormBase|WormBase | + | * [[Portal:WormBase|WormBase]] |
| - | * [[Portal:CIRM|California Institute for Regenerative Medicine | + | * [[Portal:CIRM|California Institute for Regenerative Medicine, CIRM]] |
[[Category:Portals]] | [[Category:Portals]] | ||
Revision as of 19:35, 24 August 2020
Portals within WikiPathways serve as organizing points for communities with focused pathway interests. For example, a portal could organize pathways for a particular species or research area. The main advantages of portals include:
- Simplifying drawing and databasing of your pathways
- Help to keep track of ‘works-in-progress’ with collaborators
- Help attribute credit for pathway authors and curators
- Attract new collaborators
- Help to define a community
Creating a portal is easy using existing templates available from WikiPathways. If you are interested, please consult the portal maintenance guide and contact us for assistance.
WikiPathways has a growing list of portals:
- COVID-19
- Adverse Outcome Pathway
- Lipids Pathways
- Blau Pathways
- Skeletal Dysplasia
- Clinical Proteomic Tumor Analysis Consortium Pathway
- Renal Genomics
- Disease and Rare Disease
- ExRNA Pathway
- Micronutrients
- Nanomaterials Pathways
- NetPath
- Plant Pathways
- Reactome
- WormBase
- California Institute for Regenerative Medicine, CIRM
